Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
暂无分享,去创建一个
G. Sassolas | B. Vergès | A. Beckers | A. Calender | A. Murat | P. Goudet | C. Montvernay | P. Cougard | B. Chambe | F. Boureille
[1] I. Lubensky,et al. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. , 2000, The Journal of clinical endocrinology and metabolism.
[2] D. Pauler,et al. Primary medical therapy of micro- and macroprolactinomas in men. , 2000, The Journal of clinical endocrinology and metabolism.
[3] C Béroud,et al. UMD (Universal Mutation Database): A generic software to build and analyze locus‐specific databases , 2000, Human mutation.
[4] S. Wardlaw,et al. Diagnosis and Treatment of Pituitary Tumors , 1999 .
[5] J. Webster. Clinical management of prolactinomas. , 1999, Bailliere's best practice & research. Clinical endocrinology & metabolism.
[6] R. Thakker,et al. Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours , 1999, British Journal of Cancer.
[7] J. Mulvihill,et al. The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. , 1998, Surgery.
[8] A. Colao,et al. Treatment of prolactinomas. , 1998, Annals of medicine.
[9] L. Liotta,et al. Multiple Endocrine Neoplasia Type 1: Clinical and Genetic Topics , 1998, Annals of Internal Medicine.
[10] P. Chanson,et al. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. , 1998, American journal of human genetics.
[11] S. Melmed,et al. Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors. , 1998, The Journal of clinical endocrinology and metabolism.
[12] S. Yamada,et al. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese. , 1998, The Journal of clinical endocrinology and metabolism.
[13] S. Forbes,et al. Characterization of mutations in patients with multiple endocrine neoplasia type 1. , 1998, American journal of human genetics.
[14] F. Collins,et al. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. , 1997, Cancer research.
[15] P. Beck‐Peccoz,et al. Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types , 1997, Clinical endocrinology.
[16] C. Larsson,et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. , 1997, Human molecular genetics.
[17] F. Collins,et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. , 1997, Human molecular genetics.
[18] Y Wang,et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. , 1997, Science.
[19] C. Edwards,et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1) , 1996, QJM : monthly journal of the Association of Physicians.
[20] H. Gharib,et al. Results of treatment of pituitary disease in multiple endocrine neoplasia, type I. , 1996, Neurosurgery.
[21] J. Burgess,et al. Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred. , 1996, The Journal of clinical endocrinology and metabolism.
[22] J. Burgess,et al. Prolactinomas in a large kindred with multiple endocrine neoplasia type 1: clinical features and inheritance pattern. , 1996, The Journal of clinical endocrinology and metabolism.
[23] C. Capella,et al. Pituitary lesions in multiple endocrine neoplasia syndrome (MENS) type 1. , 1995, Pathology, research and practice.
[24] I. McCutcheon. Management of individual tumor syndromes. Pituitary neoplasia. , 1994, Endocrinology and metabolism clinics of North America.
[25] G. Faglia. Epidemiology and pathogenesis of pituitary adenomas. , 1993, Acta endocrinologica.
[26] J. Rastad,et al. Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. , 1991, The Journal of clinical endocrinology and metabolism.
[27] J. Shepherd. The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized? , 1991, Archives of surgery.
[28] L. Jin,et al. Effects of estrogens on pituitary cell and pituitary tumor growth. , 1991, Pathology, research and practice.
[29] N. Ordóñez,et al. Multiple endocrine syndrome type I. Clinical, laboratory findings, and management in five families , 1989, Cancer.
[30] M. Brandi,et al. Familial multiple endocrine neoplasia type I: a new look at pathophysiology. , 1987, Endocrine reviews.
[31] B. Scheithauer,et al. Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. , 1987, Seminars in diagnostic pathology.
[32] S. D. Wilson,et al. The MEA-I syndrome: an all or none phenomenon? , 1979, Surgery.
[33] Hartsock Rj,et al. FAMILIAL MULTIPLE ENDOCRINE ADENOMA-PEPTIC ULCER COMPLEX. , 1964 .
[34] P. Wermer. ENDOCRINE ADENOMATOSIS AND PEPTIC ULCER IN A LARGE KINDRED. INHERITED MULTIPLE TUMORS AND MOSAIC PLEIOTROPISM IN MAN. , 1963, The American journal of medicine.
[35] S. Antonarakis. Recommendations for a nomenclature system for human gene mutations , 1998 .
[36] Peter J. Schaap,et al. Molecular characterization of the , 1997 .
[37] P. Chanson,et al. Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN 1. GENEM 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1. , 1997, Hormone research.
[38] B. Skogseid,et al. Multiple endocrine neoplasia type 1 (MEN-1). Clinical, biochemical and genetical investigations. , 1989, Acta oncologica.
[39] R. Caruso,et al. Hyperprolactinemia, amenorrhea, and galactorrhea. A retrospective assessment of twenty-five cases. , 1984, Annals of internal medicine.